Thermo-Ablation With Radiofrequency Medical Technologies to Treat Thyroid Cancers
The goal of this clinical trial is to test radiofrequency ablation (RFA) in thyroid cancers ≤2 cm in diameter. The main question it aims to answer is: • What is the feasibility of RFA use for low-risk thyroid cancers (≤2 cm)? Participants will undergo a set of pre-procedural scans of the target thyroid nodule and undergo the RFA procedure/intervention. Then, participants will partake in three follow-up appointments at 4 weeks, 6 months, and 12 months post-procedure as per standard of care.
⁃ 1\. Patients with:
• Nodule less than or equal to 2cm in size
• a. Specifically: Bethesda 5/6
• Their age is ≥18 years and ≤100 years
• Able to provide written consent
• Able to attend required follow-ups as per the protocol